Functionality, growth and accelerated aging of tissue engineered living autologous vascular grafts

Biomaterials

Volumn 33, Issue 33, 2012, Pages 8277-8285

  Kelm, Jens M ^a   Emmert, Maximilian Y ^a,b   Zürcher, Armin ^a   Schmidt, Dörthe ^a   Begus Nahrmann, Yvonne ^c   Rudolph, Karl L ^c   Weber, Benedikt ^a   Brokopp, Chad E ^a   Frauenfelder, Thomas ^b   Leschka, Sebastian ^b   Odermatt, Bernhard ^b   Jenni, Rolf ^b   Falk, Volkmar ^b   Zünd, Gregor ^a   Hoerstrup, Simon P ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Aging; Growth; Pulmonary artery; Telomere length; Tissue engineered vascular grafts; Tissue engineering

Indexed keywords

ACCELERATED AGING; AUTOLOGOUS TISSUE; CLINICAL PERFORMANCE; COMPUTED TOMOGRAPHY; EX-VIVO; IN-VITRO; IN-VIVO; LEUKEMIC CELLS; MULTI-STEP; PULMONARY ARTERY; TELOMERASE ACTIVITY; TELOMERE LENGTH; TELOMERES; TISSUE ENGINEERED VASCULAR GRAFTS; VASCULAR GRAFTS;

AGING OF MATERIALS; CELL CULTURE; CHROMOSOMES; COMPUTERIZED TOMOGRAPHY; GRAFTS; GROWTH (MATERIALS); TISSUE ENGINEERING;

TISSUE;

TELOMERASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL GRAFT; CELL AGING; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LIVING AUTOLOGOUS TISSUE ENGINEERED VASCULAR GRAFT; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SHEAR STRESS; TELOMERE; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REMODELING; VOLUMETRY;

AGING; ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; PULMONARY ARTERY; SHEEP; TELOMERASE; TELOMERE; TISSUE ENGINEERING;

ANIMALIA; OVIS ARIES;

EID: 84866152881     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.07.049     Document Type: Article

References (33)

1. Marelli A.J., Mackie A.S., Ionescu-Ittu R., Rahme E., Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007, 115:163-172.
2. Alexi-Meskishvili V., Ovroutski S., Ewert P., Dahnert I., Berger F., Lange P.E., et al. Optimal conduit size for extracardiac Fontan operation. Eur J Cardiothorac Surg 2000, 18:690-695.
3. Hoerstrup S.P., Cummings I., Lachat M., Schoen F.J., Jenni R., Leschka S., et al. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 2006, 114:159-166.
4. Mol A., Smits A.I., Bouten C.V., Baaijens F.P. Tissue engineering of heart valves: advances and current challenges. Expert Rev Med Devices 2009, 6:259-275.
5. Schmidt D, Dijkman PE, Driessen-Mol A, Stenger R, Mariani C, Puolakka A, et al. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol 56:510-520.
6. Sodian R., Lemke T., Fritsche C., Hoerstrup S.P., Fu P., Potapov E.V., et al. Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering. Tissue Eng 2002, 8:863-870.
7. Isenberg B.C., Williams C., Tranquillo R.T. Small-diameter artificial arteries engineered in vitro. Circ Res 2006, 98:25-35.
8. L'Heureux N., Dusserre N., Marini A., Garrido S., de la Fuente L., McAllister T. Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat Clin Pract Cardiovasc Med 2007, 4:389-395.
9. Allsopp R.C., Chang E., Kashefi-Aazam M., Rogaev E.I., Piatyszek M.A., Shay J.W., et al. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 1995, 220:194-200.
10. Chang E., Harley C.B. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 1995, 92:11190-11194.
11. Hao L.Y., Armanios M., Strong M.A., Karim B., Feldser D.M., Huso D., et al. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 2005, 123:1121-1131.
12. Demerath E.W., Cameron N., Gillman M.W., Towne B., Siervogel R.M. Telomeres and telomerase in the fetal origins of cardiovascular disease: a review. Hum Biol 2004, 76:127-146.
13. Bekaert S., De Meyer T., Rietzschel E.R., De Buyzere M.L., De Bacquer D., Langlois M., et al. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell 2007, 6:639-647.
14. Chiang YJ, Calado RT, Hathcock KS, Lansdorp PM, Young NS, Hodes RJ. Telomere length is inherited with resetting of the telomere set-point. Proc Natl Acad Sci U S A 107:10148-53.
15. Fuster J.J., Andres V. Telomere biology and cardiovascular disease. Circ Res 2006, 99:1167-1180.
16. De Meyer T., Rietzschel E.R., De Buyzere M.L., Langlois M.R., De Bacquer D., Segers P., et al. Systemic telomere length and preclinical atherosclerosis: the Asklepios study. Eur Heart J 2009, 30:3074-3081.
17. De Meyer T., Rietzschel E.R., De Buyzere M.L., Van Criekinge W., Bekaert S. Telomere length and cardiovascular aging: the means to the ends?. Ageing Res Rev 2011, 10:297-303.
18. Saliques S, Zeller M, Lorin J, Lorgis L, Teyssier JR, Cottin Y, et al. Telomere length and cardiovascular disease. Arch Cardiovasc Dis 103:454-459.
19. Edo M.D., Andres V. Aging, telomeres, and atherosclerosis. Cardiovasc Res 2005, 66:213-221.
20. Poon S.S., Lansdorp P.M. Quantitative fluorescence in situ hybridization (Q-FISH). Curr Protoc Cell Biol 2001, [Chapter 18]:Unit 18 14.
21. Delibasis K.S., Matsopoulos G.K., Mouravliansky N.A., Nikita K.S. A novel and efficient implementation of the marching cubes algorithm. Comput Med Imaging Graph 2001, 25:343-352.
22. Rajon D.A., Bolch W.E. Marching cube algorithm: review and trilinear interpolation adaptation for image-based dosimetric models. Comput Med Imaging Graph 2003, 27:411-435.
23. Frauenfelder T., Lotfey M., Boehm T., Wildermuth S. Computational fluid dynamics: hemodynamic changes in abdominal aortic aneurysm after stent-graft implantation. Cardiovasc Intervent Radiol 2006, 29:613-623.
24. Das B., Saini D., Seshadri M. Telomere length in human adults and high level natural background radiation. PLoS One 2009, 4:e8440.
25. Brennan M.P., Dardik A., Hibino N., Roh J.D., Nelson G.N., Papademitris X., et al. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg 2008, 248:370-377.
26. Dahl S.L., Kypson A.P., Lawson J.H., Blum J.L., Strader J.T., Li Y., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011, 3:68ra69.
27. Shinoka T., Shum-Tim D., Ma P.X., Tanel R.E., Isogai N., Langer R., et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998, 115:536-545.
28. Shum-Tim D., Stock U., Hrkach J., Shinoka T., Lien J., Moses M.A., et al. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg 1999, 68:2298-2305.
29. Hoerstrup S.P., Kadner A., Melnitchouk S., Trojan A., Eid K., Tracy J., et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 2002, 106:143-150.
30. Poh M., Boyer M., Solan A., Dahl S.L., Pedrotty D., Banik S.S., et al. Blood vessels engineered from human cells. Lancet 2005, 365:2122-2124.
31. Shin'oka T., Imai Y., Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001, 344:532-533.
32. Shin'oka T., Matsumura G., Hibino N., Naito Y., Watanabe M., Konuma T., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005, 129:1330-1338.
33. Barnhart G.R., Jones M., Ishihara T., Rose D.M., Chavez A.M., Ferrans V.J. Degeneration and calcification of bioprosthetic cardiac valves. Bioprosthetic tricuspid valve implantation in sheep. Am J Pathol 1982, 106:136-139.